Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

[Research Progress on the Mechanism of Pro-Inflammatory Regression Mediators Promoting Inflammation Regression by Regulating Immune Cells].

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases

[Mechanism of Resolvins in Reducing the Inflammation Reaction in Inflammatory Diseases].

How do sphingosine-1-phosphate affect immune cells to resolve inflammation?

Specialized pro-resolving mediator network: an update on production and actions

Advance in Pro-Resolution Lipid Mediators and Mechanisms of Inflammation Resolution

Mesenchymal Stem Cells Prevent Overwhelming Inflammation and Reduce Infection Severity Via Recruiting CXCR3+ Regulatory T Cells

Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

Roles of Resolvins in Chronic Inflammatory Response

Design of nanoformulation of specialized pro-resolving mediators to facilitate inflammation resolution and disease treatment

Research proress of TAM receptor tyrosine kinases in negatively regulating the inflammation

New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

The Research Progress of Resolvin Reducing Pulmonary Inflammation

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Post-transcriptional Regulation of Myeloid Cell-Mediated Inflammatory Responses.

[Research advance on the role of pro-inflammatory cytokines in sepsis].

Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation

Lipid mediators in neutrophil biology: inflammation, resolution and beyond